We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 860 results
  1. Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

    Background

    The association between antiseizure medications (ASMs) and suicidality remains controversial. Analyses of additional datasets are needed to...

    Emily E. Leppien, Bennett J. Doughty, ... Kenneth L. McCall in Clinical Drug Investigation
    Article 15 May 2023
  2. Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy

    Background

    Antiseizure medication (ASM) as monotherapy or in combination is the treatment of choice for most patients with epilepsy. Therefore,...

    Laurent M. Willems, Milena van der Goten, ... Adam Strzelczyk in CNS Drugs
    Article Open access 04 June 2023
  3. Continuous Electroencephalogram and Antiseizure Medication Use in an International Pediatric Traumatic Brain Injury Population

    Background

    Electrographic seizures are frequent and associated with worse outcomes following traumatic brain injury (TBI). Despite this, the use of...

    Kellie C. Snooks, Ke Yan, ... Sheila J. Hanson in Neurocritical Care
    Article 22 September 2021
  4. The Effect of Levetiracetam Compared with Enzyme-Inducing Antiseizure Medications on Apixaban and Rivaroxaban Peak Plasma Concentrations

    Background and Objective

    Post-stroke epilepsy represents an important clinical challenge as it often requires both treatment with direct oral...

    Rachel Goldstein, Natalie Rabkin, ... Mordechai Muszkat in CNS Drugs
    Article Open access 23 March 2024
  5. Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective

    Abstract Background

    There is little and controversial information about changes in plasma concentrations (PCs) or clinical events during...

    Federica Ranzato, Roberta Roberti, ... Gianfranco Di Gennaro in Neurological Sciences
    Article Open access 07 August 2023
  6. Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis

    Objectives

    To compare the efficacy and safety of antiseizure medications (ASMs), both as monotherapies and adjunctive therapies, for idiopathic...

    Hongyuan Chu, **nyu Zhang, ... Xu Yang in Journal of Neurology
    Article Open access 28 June 2023
  7. Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis

    Background

    Overall, up to one-third of epilepsy patients have drug-resistant epilepsy. However, there was previously no meta-analysis to support the...

    Hecheng Wang, Haoran Wang, ... Yanshuo Han in CNS Drugs
    Article 17 August 2023
  8. Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials

    Introduction

    This article aimed to assess the efficacy and tolerability of adjunctive brivaracetam (BRV) in adults with focal-onset seizures on...

    Brian Moseley, Dimitrios Bourikas, ... Simon Borghs in Advances in Therapy
    Article Open access 15 February 2024
  9. Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication

    Yaroslav Winter, Katharina Sandner, ... Sergiu Groppa in Journal of Neurology
    Article Open access 17 October 2023
  10. Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations

    Introduction

    Our objective was to provide expert consensus recommendations to improve treatment tolerability through dose adjustments of concomitant...

    Michael C. Smith, Pavel Klein, ... William E. Rosenfeld in Neurology and Therapy
    Article Open access 03 September 2022
  11. Impact of Antiseizure Medications on Appetite and Weight in Children

    There are numerous potential factors that may affect growth in children with epilepsy, and these must be evaluated in any child with appetite and...

    Ersida Buraniqi, Hicham Dabaja, Elaine C. Wirrell in Pediatric Drugs
    Article 21 May 2022
  12. A Review of the Selected and Newer Antiseizure Medications Used in Childhood Epilepsies

    There have been additions of newer antiseizure medications in the armamentarium of clinicians for the management of epilepsy. The newer antiseizure...

    Samata Singhi, Ajay Gupta in Indian Journal of Pediatrics
    Article 10 August 2021
  13. A pilot study on identifying gene signatures as markers for predicting patient response to antiseizure medications

    The majority of the biomarkers were associated with the diagnosis of epilepsy and few of them can be applied to predict the response to antiseizure...

    Yifei Duan, Liyuan Kang, ... Lei Chen in Neurological Sciences
    Article 20 January 2023
  14. Clinically Relevant Interactions Between Ritonavir-Boosted Nirmatrelvir and Concomitant Antiseizure Medications: Implications for the Management of COVID-19 in Patients with Epilepsy

    Ritonavir-boosted nirmatrelvir (RBN) has been authorized recently in several countries as an orally active anti-SARS-CoV-2 treatment for patients at...

    Maor Wanounou, Yoseph Caraco, ... Emilio Perucca in Clinical Pharmacokinetics
    Article 27 July 2022
  15. Incidence of Acute Renal Failure in Patients Using Levetiracetam Versus Other Antiseizure Medications: A Voluntary Post-Authorization Safety Study

    Introduction

    Acute kidney injury is an expected adverse drug reaction listed in the European Union (EU) Summary of Product Characteristics (SmPC) for...

    Raphaelle Beau-Lejdstrom, Lai San Hong, ... Nadia Foskett in Drug Safety
    Article 28 June 2022
  16. Attention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal Period

    Background

    An increasing number of women of reproductive age are treated with attention-deficit hyperactivity disorder (ADHD) medication; however,...

    Kathrine Bang Madsen, Mette Bliddal, ... **aoqin Liu in CNS Drugs
    Article Open access 15 March 2024
  17. Additional Results from Two Randomized, Placebo-Controlled Trials of Stiripentol in Dravet Syndrome Highlight a Rapid Antiseizure Efficacy with Longer Seizure-Free Periods

    Introduction

    The efficacy of stiripentol in Dravet syndrome children was evidenced in two randomized, double-blind, placebo-controlled, phase 3...

    Renzo Guerrini, Laurent Chancharme, ... Catherine Chiron in Neurology and Therapy
    Article Open access 09 May 2024
  18. In utero exposure to ADHD medication and long-term offspring outcomes

    Attention Deficit Hyperactivity Disorder (ADHD) medication is increasingly being used during pregnancy. Concerns have been raised as to whether ADHD...

    Kathrine Bang Madsen, Thalia K. Robakis, ... Veerle Bergink in Molecular Psychiatry
    Article 09 February 2023
  19. Prognosis and management of acute symptomatic seizures: a prospective, multicenter, observational study

    Background

    Acute symptomatic epileptic seizures are frequently seen in neurocritical care. To prevent subsequent unprovoked seizures, long-term...

    Julia Herzig-Nichtweiß, Farid Salih, ... Bernd J. Vorderwülbecke in Annals of Intensive Care
    Article Open access 15 September 2023
  20. The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond

    Epilepsy is one of the most common and disabling chronic neurological disorders. Antiseizure medications (ASMs), previously referred to as...

    Wolfgang Löscher, Pavel Klein in CNS Drugs
    Article Open access 18 June 2021
Did you find what you were looking for? Share feedback.